Showing 2,121 - 2,140 results of 3,189 for search '"vaccine"', query time: 0.08s Refine Results
  1. 2121
  2. 2122
  3. 2123

    Time to invest in cholera by Rebecca C. Stout, Nicholas Feasey, Marion Péchayre, Nicholas Thomson, Benson Z. Chilima

    Published 2025-02-01
    “…We discuss contributing factors to the outbreak including a lack of investment in water, sanitation and hygiene (both historically and currently), human resource constraints, and the market structures which make accessing oral cholera vaccine challenging both in the midst of an ongoing outbreak and as a preventative approach. …”
    Get full text
    Article
  4. 2124

    Method of obtaining and storing hyperimmune anthrax serum by S. V. Ivanova, L. A. Melnikova, A. P. Rodionov, V. V. Evstifeev

    Published 2023-09-01
    “…A live culture of Bacillus anthracis 55-VNIIVViM vaccine strain, used to produce live vaccines against animal anthrax, was used in the experiments. …”
    Get full text
    Article
  5. 2125

    Evaluation of the Acute Flaccid Paralysis Virological Surveillance System in Polio-Free Morocco, 2010–2018 by Sanae Lemrabet, Maria El Qazoui, Lalla Meryem Idrissi Azzouzi, Ahmed Rguig, Malika Elhamdaoui, Abdelkarim Filali-Maltouf, Leila Medraoui, Hicham Oumzil

    Published 2022-01-01
    “…Among the 884 AFP cases identified and analyzed, we identified 11 polioviruses as Sabin-like vaccine strains (PSL). PSL were isolated in 11 samples of AFP cases received at the laboratory, including one PSL1, three PSL2 + PSL3, one PSL1 + PSL2, and one PSL1 + 2 + 3. …”
    Get full text
    Article
  6. 2126

    Mpox (monkeypox): a comprehensive updated of current epidemic evidence by Amir Hossain, Md. Abdul Monem, Mamunur Rahman, Rashadur Raza

    Published 2025-01-01
    “…The World Health Organization (WHO) initially designated a clade Ⅱb outbreak as a global health emergency in May 2022, which was subsequently managed through vaccination and public health interventions by May 2023. …”
    Get full text
    Article
  7. 2127

    Avian adenovirus infections: diversity of pathogens, hazard to poultry industry and problems of immunoprophylaxis (review) by Yu. R. Zelenskiy, M. S. Volkov, I. A. Komarov, N. V. Moroz, N. S. Mudrak, T. V. Zhbanova

    Published 2024-03-01
    “…There is no registered vaccine against adenovirus infections that cause inclusion body hepatitis and adenoviral gizzard erosion. …”
    Get full text
    Article
  8. 2128

    PMMB COVID-19 Bulletin: Spain (18th April 2020) by Hooi-Leng Ser, Vengadesh Letchumanan, Jodi Woan-Fei Law, Loh Teng-Hern Tan, Nurul-Syakima Ab Mutalib, Learn-Han Lee

    Published 2020-04-01
    “…The Spanish government has taken counter-measures for the management of COVID-19, consisting of the announcement of “state-of-emergency” and subsequent extension to control movements, setting up research grants to expedite drug and vaccine development in addition to introduction of the use of artificial intelligence as an official channel to provide advice and enquires about COVID-19. …”
    Get full text
    Article
  9. 2129

    Overview of Community-Acquired Pneumonia and the Role of Inflammatory Mechanisms in the Immunopathogenesis of Severe Pneumococcal Disease by Helen C. Steel, Riana Cockeran, Ronald Anderson, Charles Feldman

    Published 2013-01-01
    “…Despite the implementation of national pneumococcal polyvalent vaccine-based immunisation strategies targeted at high-risk groups, Streptococcus pneumoniae (the pneumococcus) remains the most common cause of CAP. …”
    Get full text
    Article
  10. 2130

    Effect of attenueted parapoxvirus ovis on levels of some serum cytokines and antibody response in sheep by Kamil Atlı, Atilla Şimşek

    Published 2022-06-01
    “…<p> <b>Conclusion:</b> It was concluded that the vaccines against ORFV infection considered to be used in the future should be applied after the effects on the immune system have been clearly demonstrated.…”
    Get full text
    Article
  11. 2131

    Molecular epidemiology of foot-and-mouth disease (review) by A. V. Scherbakov

    Published 2024-03-01
    “…The results of molecular epidemiological studies are taken into account when vaccine strains are to be selected for preventive vaccination of livestock in FMD high-risk areas. …”
    Get full text
    Article
  12. 2132

    Geospatial Analysis of COVID-19 Death Rate and Influencing Factors in the MENA Region by MUSTAFA SHEBANI ABOALYEM, Mohd Tahir Ismail

    Published 2024-09-01
    “…The findings suggest a positive correlation between death rate, hospital bed allocation, unemployment rate, and vaccination doses, highlighting the importance of social isolation measures. …”
    Get full text
    Article
  13. 2133
  14. 2134
  15. 2135

    Editorial by Jörg Tremmel, Markus Rutsche

    Published 2022-04-01
    “… While the unprecedented lockdown measures were at the heart of the debate in the first year of the pandemic, the focus since then has shifted to vaccination issues. The reason, of course, is that vaccines and vaccinations have become available by now. …”
    Get full text
    Article
  16. 2136

    Chiral polypeptide hydrogels regulating local immune microenvironment and anti-tumor immune response by Junfeng Ding, Tianran Wang, Zhiqiang Lin, Zhenyu Li, Jiaxuan Yang, Fujiang Li, Yan Rong, Xuesi Chen, Chaoliang He

    Published 2025-01-01
    “…Abstract The impact of chirality on immune response has attracted great interest in cancer vaccine research recently. However, the study of chiral synthetic polypeptide hydrogels as cancer vaccines as well as of the impact of biomaterials themselves for antitumor immunotherapy has rarely been reported. …”
    Get full text
    Article
  17. 2137
  18. 2138

    Anti-Tn Monoclonal Antibody Ameliorates Hyperoxia-Induced Kidney Injury by Suppressing Oxidative Stress and Inflammation in Neonatal Mice by Julie Chi Chow, Hsiu-Chu Chou, Jaulang Hwang, Chung-Ming Chen

    Published 2021-01-01
    “…Maternal immunization with the Tn vaccine increases serum anti-Tn antibody titers and attenuates hyperoxia-induced kidney injury in neonatal rats. …”
    Get full text
    Article
  19. 2139

    Research Progress of Fuzheng Jiedu Huayu Method in Reducing Toxicity and Enhancing Efficacy of Immunotherapy by Yufan CHEN, Sicong LI, Yiyuan CUI, Li FENG

    Published 2025-01-01
    “…Immunotherapy, including immune checkpoint inhibitors, tumor vaccine therapy, oncolytic virotherapy, and adoptive cell therapy, has made remarkably breakthroughs in the field of oncology. …”
    Get full text
    Article
  20. 2140

    Different Transcriptional Profiles of Human Monocyte-Derived Dendritic Cells Infected with Distinct Strains of Mycobacterium tuberculosis and Mycobacterium bovis Bacillus Calmette-... by Nunzia Sanarico, Alessia Colone, Manuela Grassi, Viviana Speranza, Daniela Giovannini, Antonio Ciaramella, Vittorio Colizzi, Francesca Mariani

    Published 2011-01-01
    “…In order to analyze dendritic cells (DCs) activation following infection with different mycobacterial strains, we studied the expression profiles of 165 genes of human monocyte-derived DCs infected with H37Rv, a virulent Mycobacterium tuberculosis (MTB) laboratory strain, CMT97, a clinical MTB isolate, Mycobacterium bovis bacillus Calmette-Guérin (BCG), Aventis Pasteur, and BCG Japan, both employed as vaccine against tuberculosis. The analysis of the gene expression reveals that, despite a set of genes similarly modulated, DCs response resulted strain dependent. …”
    Get full text
    Article